-
Something wrong with this record ?
Aktuality z odborného tisku
Články vybral a komentoval: MUDr. Peter Grell, Ph.D.
Klinická onkologie.
2022 ;
35 (6) :
494-496.
Status not-indexed Language Czech Country Czech Republic
Document type Overall
Persistent link
https://www.medvik.cz/link/bmc22028431
Formatted Contents
Pembrolizumab plus chemotherapy in advanced triple-negative breast cancer -- Global burden of cancer in 2020 attributable to alcohol consumption: a population-based study -- Tumour-agnostic efficacy and safety of selpercatinib in patients with RET fusion-positive solid tumours other than lung or thyroid tumours (LIBRETTO-001): a phase 1/2, open-label, basket tria -- Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22028431
- 003
- CZ-PrNML
- 005
- 20230119090353.0
- 007
- ta
- 008
- 221220s2022 xr f 000 0|cze||
- 009
- PC
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a cze
- 044 __
- $a xr
- 100 1_
- $a Grell, Peter $7 xx0107816 $u Klinika komplexní onkologické péče LF MU a MOÚ, Brno
- 245 10
- $a Aktuality z odborného tisku / $c Články vybral a komentoval: MUDr. Peter Grell, Ph.D.
- 505 0_
- $a Pembrolizumab plus chemotherapy in advanced triple-negative breast cancer -- Global burden of cancer in 2020 attributable to alcohol consumption: a population-based study -- Tumour-agnostic efficacy and safety of selpercatinib in patients with RET fusion-positive solid tumours other than lung or thyroid tumours (LIBRETTO-001): a phase 1/2, open-label, basket tria -- Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer
- 590 __
- $a NEINDEXOVÁNO
- 655 _7
- $a souhrny $7 D016424 $2 czmesh
- 773 0_
- $w MED00011030 $t Klinická onkologie $x 0862-495X $g Roč. 35, č. 6 (2022), s. 494-496
- 856 41
- $u https://www.prolekare.cz/casopisy/klinicka-onkologie/2022-6-3/aktuality-z-odborneho-tisku-132852 $y plný text volně dostupný
- 910 __
- $a ABA008 $b B 1665 $c 656 $y p $z 0
- 990 __
- $a 20221220 $b ABA008
- 991 __
- $a 20230119090346 $b ABA008
- 999 __
- $a ok $b bmc $g 1886070 $s 1179750
- BAS __
- $a 6
- BAS __
- $a PreBMC
- BMC __
- $a 2022 $b 35 $c 6 $d 494-496 $i 0862-495X $m Klinická onkologie $x MED00011030 $y 132852
- LZP __
- $b NLK111 $a Meditorial-20221220
